Model Guardant Reveal - Residual Disease Detection And Recurrence Monitoring
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects circulating tumor DNA (ctDNA) in blood after surgery to identify patients with residual disease who may benefit most from adjuvant therapy. Our first indication is early-stage colorectal cancer with additional cancer types to follow.
-
Most popular related searches
Customer reviews
No reviews were found for Model Guardant Reveal - Residual Disease Detection And Recurrence Monitoring. Be the first to review!